Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased ...

The FDA has approved Cabometyx (cabozantinib) for previously treated, unresectable, locally advanced or metastatic, well-differentiated neuroendocrine tumors.

Neoadjuvant combination immunotherapy may improve survival compared with single-agent therapy for patients with head and neck ...

Results of study directed by Rodrigo Toledo, Head of the Vall d'Hebron Institute of Oncology's (VHIO) Biomarkers and Clonal ...

New data shows South County Fire’s cardiac arrest survival rate 1 is 71%, nearly double the national average. “Firefighters are very deliberately focused on providing the absolute best CPR for your ...

The gut microbiome has emerged as a potential factor in cancer pathogenesis, but its role in non-functioning pituitary neuroendocrine tumors (NF-PitNETs) remains unclear. This study aimed to elucidate ...

the more serious type of skin cancer, the survival rate has improved significantly to 92%, a report by the National Cancer Registry of Ireland has found. Linda Chanders, aged 54, was first ...

The approval was based on progression-free survival (PFS) and overall response rates (ORRs ... of Dana-Farber Cancer Institute, Boston, stated in a press release from Exelixis.

For melanoma, the more serious type of skin cancer, survival rates have improved significantly to 92pc, meaning nine out of 10 patients survive at least five years. Join the Irish Independent ...